SCINTIPHARMA, Inc. is a privately held company focused on problem solving in the field of pharmaceutical dosage form development. The company's main objective is to provide services to the pharmaceutical industry for the optimization of drug delivery systems. The primary mission is improved delivery of currently marketed and potentially marketable therapeutic agents in the gastrointestinal tract as well as other routes such as nasal, ocular, inhalation, or rectal. Some of the world's principal experts in pharmaceutical drug delivery are available for consultation. Scintipharma staff received their formal training from and continue to consult the innovating pioneer of gamma scintigraphy in pharmaceutical research. Pharmaceutical formulation and gamma scintigraphic studies have been performed for many of the pharmaceutical industries leading companies. For further information, contact:Scintipharma, Inc.Walter J. Doll, Ph.D.1721 Maywick View LaneLexington, Kentucky 40504 USATel: (859) 276-3320Fax: (859) 276-3234e-mail: wdoll@scintipharma.com[Home] [What is Gamma Scintigraphy? ] [Why use Gamma Scintigraphy? ] [About the InteliSite capsule ] [About Scintipharma ]
View Top Employees from Scintipharma Inc| Website | http://www.scintipharma.com |
| Revenue | $3 million |
| Employees | View employees |
| Address | 1721 Maywick View Ln, Lexington, Kentucky 40504, US |
| Phone | (859) 276-3320 |
| Fax | (859) 276-3234 |
| Industry | Drug Stores & Pharmacies, Pharmaceutical, Retail, Health Care |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Scintipharma Inc employee's phone or email?
Scintipharma Inc Questions
The Scintipharma Inc annual revenue was $3 million in 2024.
Scintipharma Inc is based in Lexington, Kentucky.
The NAICS codes for Scintipharma Inc are [32, 325, 3254, 32541].
The SIC codes for Scintipharma Inc are [283, 28].
